Gynaecological cancer screening and preventionFIANDER, Alison.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2006, Vol 20, Num 2, issn 1521-6934, 193 p.Serial Issue

The effect of lifestyle factors on gynaecological cancerRIECK, Gudrun; FIANDER, Alison.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2006, Vol 20, Num 2, pp 227-251, issn 1521-6934, 25 p.Article

transportMYpatient: an initiative to overcome the barrier of transport costs for patients accessing treatment for obstetric fistulae and cleft lip in TanzaniaFIANDER, Alison Nina; VANNESTE, Tom.Tropical doctor. 2012, Vol 42, Num 2, pp 77-79, issn 0049-4755, 3 p.Article

HPV vaccinesSTANLEY, Margaret.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2006, Vol 20, Num 2, pp 279-293, issn 1521-6934, 15 p.Article

HPV information needsTRISTRAM, Amanda.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2006, Vol 20, Num 2, pp 267-277, issn 1521-6934, 11 p.Article

Chemoprevention of cervical cancerSASIENI, Peter.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2006, Vol 20, Num 2, pp 295-305, issn 1521-6934, 11 p.Article

Vulval cancer : prevention and screeningMACLEAN, Allan B.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2006, Vol 20, Num 2, pp 379-395, issn 1521-6934, 17 p.Article

Familial ovarian cancer screeningROSENTHAL, Adam; JACOBS, Ian.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2006, Vol 20, Num 2, pp 321-338, issn 1521-6934, 18 p.Article

Recovery of human papillomavirus nucleic acids from liquid-based cytology mediaPOWELL, Ned; SMITH, Kelly; FIANDER, Alison et al.Journal of virological methods. 2006, Vol 137, Num 1, pp 58-62, issn 0166-0934, 5 p.Article

Human papillomavirus, cervical carcinogenesis and chemoprevention with Indole derivates : a review of pathomechanismsRIECK, Gudrun C; FIANDER, Alison N.Molecular nutrition & food research (Print). 2008, Vol 52, Num 1, pp 105-113, issn 1613-4125, 9 p.Article

Worldwide burden of gynaecological cancer : The size of the problemSANKARANARAYANAN, R; FERLAY, I.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2006, Vol 20, Num 2, pp 207-225, issn 1521-6934, 19 p.Article

Screening for ovarian cancer in the general populationCHU, Christina S; RUBIR, Stephen C.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2006, Vol 20, Num 2, pp 307-320, issn 1521-6934, 14 p.Article

Immunology of human papillomavirus infection in lower genital tract neoplasiaMAN, Stephen; FIANDER, Alison.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2001, Vol 15, Num 5, pp 701-714, issn 1521-6934Article

Prevention of ovarian cancerHANNA, Louise; ADAMS, Malcolm.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2006, Vol 20, Num 2, pp 339-362, issn 1521-6934, 24 p.Article

Screening and the prevention of gynecologic cancer : Endometrial cancerSONODA, Yukio; BARAKAT, Richard R.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2006, Vol 20, Num 2, pp 363-377, issn 1521-6934, 15 p.Article

The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: An observational retrospective analysis of invasive cervical cancersPOWELL, Ned; BOYDE, Adam; TRISTRAM, Amanda et al.International journal of cancer (Print). 2009, Vol 125, Num 10, pp 2425-2427, issn 0020-7136, 3 p.Article

Epidemiology of pelvic organ prolapse in rural Gambia, West AfricaSCHERF, Caroline; MORISON, Linda; FIANDER, Alison et al.BJOG (Oxford. Print). 2002, Vol 109, Num 4, pp 431-436, issn 1470-0328Article

HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytologyLORINCZ, Attila T; BRENTNALL, Adam R; VASILJEVIC, Nataša et al.International journal of cancer (Print). 2013, Vol 133, Num 3, pp 637-644, issn 0020-7136, 8 p.Article

Human Papillomavirus genotype testing combined with cytology as a 'test of cure' post treatment: The importance of a persistent viral infectionJONES, Joanne; SALEEM, Azka; RAI, Nima et al.Journal of clinical virology. 2011, Vol 52, Num 2, pp 88-92, issn 1386-6532, 5 p.Article

Human Papillomavirus Type Distribution in Vulval Intraepithelial Neoplasia Determined Using PapilloCheck DNA MicroarrayBRYANT, Dean; RAI, Nirmala; ROWLANDS, Gareth et al.Journal of medical virology. 2011, Vol 83, Num 8, pp 1358-1361, issn 0146-6615, 4 p.Article

HPV testing in cervical screeningBRINK, Antoinette A. T. P; SNIJDERS, Peter J. F; MEIJER, Chris I. L. M et al.Baillière's best practice & research. Clinical obstetrics & gynaecology. 2006, Vol 20, Num 2, pp 253-266, issn 1521-6934, 14 p.Article

Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in EuropeTIALMA, Wiebren A; FIANDER, Alison; COLAU, Brigitte et al.International journal of cancer (Print). 2013, Vol 132, Num 4, pp 854-867, issn 0020-7136, 14 p.Article

The risk of cervical cancer associated with specific types of human papillomavirus: a case-control study in a UK populationPOWELL, Ned G; HIBBITTS, Sam J; BOYDE, Adam M et al.International journal of cancer (Print). 2011, Vol 128, Num 7, pp 1676-1682, issn 0020-7136, 7 p.Article

HPV16 E6_29-38-specific T cells kill cervical carcinoma cells despite partial evasion of T-cell effector functionTHOMAS, Karen J; SMITH, Kelly L; YOUDE, Sarah J et al.International journal of cancer. 2008, Vol 122, Num 12, pp 2791-2799, issn 0020-7136, 9 p.Article

Novel method for detection, typing, and quantification of human papillomaviruses in clinical samplesHART, Keith W; WILLIAMS, O. Martin; THELWELL, Nicola et al.Journal of clinical microbiology (Print). 2001, Vol 39, Num 9, pp 3204-3212, issn 0095-1137Article